Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Edlin

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Neonatology|June 13, 2018
Cost Analysis of Cot-Side Screening Methods for Neonatal HypoglycaemiaMatthew J Glasgow, Jane E Harding, Richard Edlin, et al.
BMJ Open|September 17, 2020
Comparison of risk-of-bias assessment approaches for selection of studies reporting prevalence for economic analysesMatthew J Glasgow, Richard Edlin, Jane E Harding
British Journal of Clinical Pharmacology|August 19, 2010
Cost-effectiveness analysis and efficient use of the pharmaceutical budget: the key role of clinical pharmacologistsRichard Edlin, Jeff Round, Claire Hulme, et al.
BMJ Open|June 24, 2015
Cost-effectiveness of the New Zealand diabetes in pregnancy guideline screening recommendationsCatherine Coop, Richard Edlin, Julie Brown, et al.
The Journal of Pediatrics|April 8, 2018
Cost Analysis of Treating Neonatal Hypoglycemia with Dextrose GelMatthew J Glasgow, Jane E Harding, Richard Edlin, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 28, 2014
Sharing risk between payer and provider by leasing health technologies: an affordable and effective reimbursement strategy for innovative technologies?Richard Edlin, Peter Hall, Klemens Wallner, et al.
Health Policy (Amsterdam, Netherlands)|October 22, 2008
Examining the attitudes and preferences of health care decision-makers in relation to access, equity and cost-effectiveness: a discrete choice experimentJulie Ratcliffe, Hilary L Bekker, Paul Dolan, et al.
Pharmaceutical Statistics|February 21, 2018
Bayesian statistical models to estimate EQ-5D utility scores from EORTC QLQ data in myelomaSamer A Kharroubi, Richard Edlin, David Meads, et al.
Plos One|December 20, 2021
Suicide preceded by health services contact - A whole-of-population study in New Zealand 2013-2015Annie Chiang, Janine Paynter, Richard Edlin, et al.
Pharmacoeconomics|January 21, 2010
Principles of design of access with evidence development approaches: a consensus statement from the Banff SummitDevidas Menon, Christopher J McCabe, Tania Stafinski, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Neonatology|June 13, 2018
Cost Analysis of Cot-Side Screening Methods for Neonatal HypoglycaemiaMatthew J Glasgow, Jane E Harding, Richard Edlin, et al.
BMJ Open|September 17, 2020
Comparison of risk-of-bias assessment approaches for selection of studies reporting prevalence for economic analysesMatthew J Glasgow, Richard Edlin, Jane E Harding
British Journal of Clinical Pharmacology|August 19, 2010
Cost-effectiveness analysis and efficient use of the pharmaceutical budget: the key role of clinical pharmacologistsRichard Edlin, Jeff Round, Claire Hulme, et al.
BMJ Open|June 24, 2015
Cost-effectiveness of the New Zealand diabetes in pregnancy guideline screening recommendationsCatherine Coop, Richard Edlin, Julie Brown, et al.
The Journal of Pediatrics|April 8, 2018
Cost Analysis of Treating Neonatal Hypoglycemia with Dextrose GelMatthew J Glasgow, Jane E Harding, Richard Edlin, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 28, 2014
Sharing risk between payer and provider by leasing health technologies: an affordable and effective reimbursement strategy for innovative technologies?Richard Edlin, Peter Hall, Klemens Wallner, et al.
Health Policy (Amsterdam, Netherlands)|October 22, 2008
Examining the attitudes and preferences of health care decision-makers in relation to access, equity and cost-effectiveness: a discrete choice experimentJulie Ratcliffe, Hilary L Bekker, Paul Dolan, et al.
Pharmaceutical Statistics|February 21, 2018
Bayesian statistical models to estimate EQ-5D utility scores from EORTC QLQ data in myelomaSamer A Kharroubi, Richard Edlin, David Meads, et al.
Plos One|December 20, 2021
Suicide preceded by health services contact - A whole-of-population study in New Zealand 2013-2015Annie Chiang, Janine Paynter, Richard Edlin, et al.
Pharmacoeconomics|January 21, 2010
Principles of design of access with evidence development approaches: a consensus statement from the Banff SummitDevidas Menon, Christopher J McCabe, Tania Stafinski, et al.
Pageof 6